Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Molecular FormulaC23H19F2N5O |
InChIKeyZHJVVJVGTOZLTH-SCADIAGYSA-N |
CAS Registry2209122-25-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Phase 2 | CA | - |